Nuzenio

Nintedanib

Nintedanib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil - ERS - European Respiratory SocietyERS - European Respiratory Society · Sun, 09 Aug 2026 02:42:57 GMTWhy MannKind (MNKD) Is Up 5.1% After Positive Inhaled Nintedanib Data Despite Q2 Net Loss - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:32:25 GMTNintedanib dry powder inhalation therapy has favorable safety, tolerability in IPF - HealioHealio · Fri, 07 Aug 2026 20:09:31 GMTSAHPRA Recalls Specific Batches of ENO, Aqueous Cream and Lung Medication - Newcastillian NewsNewcastillian News · Mon, 03 Aug 2026 10:44:39 GMTMannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for IPF - Slideshow (NASDAQ:MNKD) 2026-07-30 - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTMannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway - TradingViewTradingView · Wed, 29 Jul 2026 23:04:07 GMTMannKind Reports Positive Phase 1b INFLO-1 Results, - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 10:30:00 GMT

Timeline

Sun, 09 Aug 2026 02:42:57 GMTChanges in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil - ERS - European Respiratory Society
Sat, 08 Aug 2026 17:32:25 GMTWhy MannKind (MNKD) Is Up 5.1% After Positive Inhaled Nintedanib Data Despite Q2 Net Loss - simplywall.st
Fri, 07 Aug 2026 20:09:31 GMTNintedanib dry powder inhalation therapy has favorable safety, tolerability in IPF - Healio
Mon, 03 Aug 2026 10:44:39 GMTSAHPRA Recalls Specific Batches of ENO, Aqueous Cream and Lung Medication - Newcastillian News
Thu, 30 Jul 2026 07:00:00 GMTMannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for IPF - Slideshow (NASDAQ:MNKD) 2026-07-30 - Seeking Alpha
Wed, 29 Jul 2026 23:04:07 GMTMannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nintedanib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.